[PMA] + ionomycin; PHA; anti-CD3 + anti-CD28 antibodies). In an interesting study performed in human volunteers receiving an injection of endotoxin, Lauw et al. 10 showed that depressed IL-2 production could not be revealed with the use of the anti-CD3 + anti-CD28 cocktail but only with the use of the staphylococcal enterotoxin B (SEB) superantigen. In contrast, both agents were associated with a reduced production of IFN-γ, an enhanced production of IL-5 and an unchanged production of IL-4. In a study performed in sepsis patients, we confirmed the importance of the nature of the activating signal to demonstrate the presence of cellular hyporeactivity: 11 PHA stimulation was associated with an unmodified production of T-cell-derived cytokines as compared to healthy controls whereas concanavalin A (ConA) stimulation was associated with a significant reduction of both Th1 (IL-2) and Th2 (IL-5, IL-10) cytokines. In cardiopulmonary by-pass patients, ConA-induced activation led to cytokine release similar to that in healthy controls whereas a reduced IL-10 production was obtained when anti-CD3 activation was used. 11 Altogether, these studies establish that the demonstration of the reduced capacity of lymphocytes to produce cytokines observed in SIRS patients is greatly influenced by the nature of the activating signal. This implies that not all signalling pathways are altered in lymphocytes of SIRS patients. Furthermore, infectious as well as non-infectious inflammatory processes exert a subtle modulation on circulating lymphocyte reactivity that can lead to a down-regulation of both Th1 and Th2 cytokines.
Monocytes
Monocyte reactivity to lipopolysaccharide (LPS) stimulation has been particularly well studied in isolated monocytes and in whole-blood assays. Monocytes from septic patients have a diminished capacity to release TNF-α, IL-1α, IL-1β, IL-6, IL-10 and IL-12, 2,12-17 whereas this is not the case for IL-1ra. 15 Reduced cytokine production has also been observed with other stimuli such as silica, staphylococcal enterotoxin B, killed Streptococcus pyogenes and Staphylococcus aureus. 2, [18] [19] [20] Similar observations were reported in human volunteers after an LPS injection: the production of IL-1, TNF-α and IL-6 by peripheral blood mononuclear cells (PBMC) was significantly reduced independently of the nature of the activating agent (i.e. LPS, IL-1β, staphylococcal toxic shock syndrome toxin-1). 21 However, the use of some stimuli failed to demonstrate the hyporeactivity of monocytes in sepsis or trauma patients. This was particularly the case when TNF-α production was induced by muramyl-dipeptide (MDP) employed either alone 22 or in combination with IFN-γ. 23 In contrast, the use of MDP was always associated with a decreased production of IL-10 in trauma and burn patients. 8 For our part, we found that IL-10 production by isolated PBMC upon activation by LPS was significantly reduced in sepsis; this was not the case when heat killed Staph. aureus was employed. 11 Similarly, in a recent investigation on blood samples from patients after cardiac arrest and resuscitation, a unique model of systemic ischemia and reperfusion, we showed a profound impaired production of TNF-α and IL-6 in response to LPS whereas this was not the case when heat killed Staph. aureus was used (manuscript in preparation). Likewise, when PMA was used as a triggering agent, TNF-α and IL-1β production by monocytes from patients with severe sepsis were not significantly lower than in healthy controls. 20 A reduced PMA-induced TNF-α production was only noticed in the case of septic shock. Accordingly, in an in vitro model of endotoxin tolerance, we showed that human monocytes rendered tolerant to LPS responded normally to PMA although they were hyporeactive to Strep. pyogenes, Zymosan and Staph. aureus. 24 Thus, despite the fact that sepsis and non-infectious SIRS are always associated with a reduced capacity of monocytes to produce cytokines in response to LPS, there are few examples that demonstrate an unaltered reactivity of monocytes to certain stimuli. Further insights will be required to understand whether these discrepancies reflect differentially altered and unmodified signalling pathways following stressful conditions.
Neutrophils
A similar hyporeactivity has been reported for the production of IL-1β, IL-1ra and IL-8 by LPS-activated neutrophils (PMN) from septic patients. McCall et al. 25 reported that the reduced production of IL-1β by PMN was specifically observed with LPS but not with Staph. aureus. In contrast, we found that reduced production of IL-8 and IL-1ra was observed using LPS as well as Strep. pyogenes. 26, 27 The anergy of neutrophils observed in septic patients has been associated with the phenomenon of endotoxin tolerance. 25 Indeed, in human volunteers intravenously challenged with LPS, the capacity of PMNs to produce IL-8 and other chemokines in vitro in response to LPS and heat killed Gram-negative or Gram-positive bacteria was dramatically decreased. 28 However, we have shown that, in contrast to monocytes which can be rendered tolerant in vitro, LPS fails to render neutrophils tolerant in vitro to a second stimulation with LPS. 26 
Causative mediators
Anti-inflammatory cytokines, particularly IL-10 and transforming growth factor-β (TGF-β) are potent deactivators of leukocytes and can block most of cytokine production. Accordingly, these cytokines were recognized as responsible for monocyte hyporeactivity observed in LPS-tolerant cells. 17, 24 IL-10 was identified as a major functional de-activator of human monocytes in human septic shock plasma. 29 TGF-β was shown in animal models of hemorrhagic shock and of sepsis to be the causative agent of the depressed splenocyte responsiveness. 30, 31 Furthermore, there is accumulating evidence for a strong interaction between components of the nervous and the immune systems, and numerous neuromediators have been shown to behave as immunosuppressors. Catecholamines suppress the activity of immunocompetent cells and are found to be at higher concentrations in stressful situations. 32 Catecholamines are known to inhibit TNF production 33 and to favor IL-10 release. 34, 35 Similarly, α-melanocyte-stimulating hormone contributes to immunosuppression by inducing IL-10 production by human monocytes. 36 In addition, vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide directly inhibit endotoxin induced pro-inflammatory cytokine secretion. 37, 38 Furthermore, SIRS models are associated with an activation of the serotonin (5-HT) metabolism 39 and the central serotoninergic neurotransmission. 40 An increase in the serotoninergic activity has been observed during sepsis in rat brain. 41 Moreover, it has been reported that an increase or a decrease in 5-HT concentrations, respectively, inhibit or enhance immune responses. 42, 43 SIRS is also associated with an activation of the hypothalamuspituitary-adrenal axis which leads to the release of glucocorticoids, well known for their potent ability to limit the cytokine production. 44 Finally, prostaglandins are produced during sepsis and can also contribute to the down-regulation of cytokine production. 45 To define this phenomenon, Bone 46 coined the acronym CARS for 'compensatory anti-inflammatory response syndrome'. Bone proposed that at a given time, SIRS or CARS predominates in patients, inducing shock or immune depression, respectively.
CONCEPT OF COMPARTMENTALIZATION
We postulate that SIRS and CARS should not be opposed, but most probably occur concomitantly in different compartments: SIRS predominates within the inflamed tissues while blood leukocytes show hyporeactivity.
The measurement of inflammatory mediators (e.g. cytokines, iNOS) are in agreement with the concept of a compartmentalization of inflammation. Indeed, iNOS activity and the presence of IL-1β and TNF were found to be restricted to the nidus of infection in patients undergoing a septic shock after cellulitis. 47 TNF and IL-6 were more elevated in cerebrospinal fluids than in plasma of patients with meningitis. 48 After chest trauma, significantly higher levels of IL-1β and IL-8 were found in broncho-alveolar lavage fluids than in plasma, whereas anti-inflammatory mediators (sTNFRI, sTNFRII, and IL-1ra) were present both locally and systematically. 49 Spontaneous TNF mRNA expression was detected in 66 ± 14% of alveolar macrophages from patients with acute respiratory distress syndrome (ARDS) while only 6% of these cells express these mRNAs in healthy controls. 50 High levels of IL-8 and matrix metalloproteinase-9 found in edema fluids of ARDS patients were associated with a proinflammatory activity of these fluids, whereas pro-inflammatory activity was undetectable in plasma of ARDS patients. 51 Measurement of pro-inflammatory cytokines and anti-inflammatory mediators in pleural fluids also suggested the occurrence of both systemic and compartmentalized response in septic as well as in non-septic patients. 52 Finally, compartmentalized cytokine production was elegantly demonstrated by Dehoux et al. 53 who showed higher levels of inflammatory cytokines in broncho-alveolar lavage (BAL) fluids recovered from involved lung of patients with unilateral pneumonia as compared to the contralateral, non-involved lung. In this study, the authors showed that the production of IL-1, IL-6, and TNF by alveolar macrophages activated with LPS were reduced as compared to the responses obtained with cells recovered from healthy controls.
However, in contrast to this report which deals with a local infectious process, and in contrast to the hyporeactivity of the circulating leukocytes, it has often been shown that cells derived from the inflamed tissues are activated, primed and fully respond to ex vivo stimulation. In ARDS patients, alveolar macrophages displayed an enhanced capacity of producing IL-1 after ex vivo stimulation with LPS alone or together with IFN-γ. 54 Interestingly, in human volunteers, Smith et al. 55 reported that intravenous endotoxin primed alveolar macrophages for an enhanced in vitro LPS-induced production of IL-1, TNF and PGE 2 . In a hemorrhagic shock model performed in rats, it was demonstrated that a further in vivo administration of LPS led to an enhanced expression of the CICN and MIP-2 chemokines in lung tissues. Furthermore, in vitro LPS-activation of alveolar macrophages recovered from shock-resuscitated animals led to an enhanced CICN release as compared to alveolar macrophages derived from sham animals. 56 In a collaborative study performed with Dr Hoffschir (CEA, Orsay, France), we analyzed the reactivity of alveolar macrophages derived from baboons who had undergone unilateral lung irradiation. As shown in Figure 1 , in the days following irradiation, not only the spontaneous productions of IL-8 and TNF were enhanced, but those induced by LPS, Staph. aureus and Strep. pyogenes were increased as compared to the responses obtained with the alveolar macrophages recovered before irradiation.
Similar observations have been reported with cell types other than alveolar macrophages. For example, the Fig. 1 . In vitro production of IL-8 and TNF-α (mean ± SEM] by alveolar macrophages (5 x 10 5 /ml) derived from broncho-alveolar lavages performed in baboons (n = 5) before (day 0) and after left lung unilateral irradiation (15 Gy). Spontaneous as well as E. coli LPS (1 µg/ml), Staph. aureus Cowan I (100 µg/ml) and heat-killed Strep. pyogenes (10 7 CFU/ml) induced cytokine productions were assessed in 24 h culture supernatants by ELISA for human cytokines which cross-reacted with baboon cytokines. Similar results were obtained from alveolar macrophages harvested from the right lung. study of peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients revealed that LPS-activated cells released significantly more IL-1β during peritonitis compared with the infection-free period. 57 In women with endometriosis, spontaneous and LPS-induced production of TNF-α, IL-6, IL-8, IL-10, IL-12 and nitric oxide (NO) by peritoneal macrophages were higher than in controls. 58, 59 In patients with inflammatory bowel disease, adherent lamina propria mononuclear cells activated with pokeweed mitogen or with a combination of LPS and IFN-γ displayed an up-regulated production of TNF-α, IL-1α, IL-1β and IL-6. 60 The consequences of a systemic inflammatory process have also been analyzed at a local level. The study on hemorrhagic shock led to controversial results: Zhu et al. 61 showed an increased TNF-α, IL-1β and IL-6 mRNA expression by LPS-activated peritoneal macrophages whereas a reduced production of TNF-α was reported by Kramer et al. 62 In a thermal injury model performed in rats, there was no change of LPS-induced TNF production by Kupffer cells whereas LPS-induced IL-6 production was enhanced. 63 Altogether, these numerous examples illustrate that leukocyte hyporeactivity subsequent to sepsis or SIRS is essentially observed in hematopoietic compartments (blood stream in patients and in LPS-challenged volunteers, spleen in animal models), whereas during localized inflammation the cells derived from tissues are not rendered hyporeactive. Their state of activation may illustrate the on-going process of inflammation as illustrated by the high levels of cytokines measured in the related biological fluids. It is worth noting that cells derived from inflammatory foci may be far less sensitive to anti-inflammatory mediators. This was elegantly demonstrated by Pang et al. 64 who showed, in chronic bronchial sepsis patients, that the production of IL-8 by PMN derived from sputum was not significantly reduced by the addition of increasing amounts of IL-10 in contrast to the inhibitory effect of IL-10 on circulating PMN. Similarly, we recently showed that IL-8 production by sputum PMN from cystic fibrosis patients was insensitive to the effects of dexamethasone when employed at a concentration (10 -6 M) which was efficient on blood PMN (Corvol H, Cavaillon J-M, Clément A. submitted).
NUCLEAR FACTOR-κB STATUS AS A MARKER OF

HYPO-OR HYPER-REACTIVITY
Nuclear factor-κB (NF-κB) is one of the main factors required for the transcription of numerous genes of inflammatory mediators. Thus, its status may provide further insight into the mechanisms of activation or deactivation of the cells. An enhanced activation of the transcription factor NF-κB was reported in lung mononuclear cells and lung neutrophils after hemorrhage in mice 65, 66 and in the lung and liver of mice with peritonitis. 67, 68 Similarly, after hemorrhage or LPS injection, NF-κB was activated in lung neutrophils whereas it was not in the circulating neutrophils. 66 Similarly, an increased activation of NF-κB was demonstrated in alveolar macrophages of patients with acute respiratory distress syndrome (ARDS). 69 The first reported analysis in septic patients, showed a higher ex vivo nuclear expression of NF-κB in PBMC of non-survivors. 70 We performed a similar study and confirmed that total NF-κB content was higher in the nucleus of PBMC from non-survivors as compared to survivors of severe sepsis, but we specified that the nuclear levels of NF-κB were lower in surviving sepsis patients than in healthy controls. 71 However, in SIRS patients, very few studies have analyzed NF-κB expression in leukocytes following in vitro LPS-activation. Such analysis would indicate whether the ex vivo state of activation reproduces the NF-κB expression described in in vitro tolerized cells. On the one hand, Ziegler-Heitbrock et al. 72 reported an enhanced expression of the NF-κB homodimer p50p50, the inactive form, as compared to the NF-κB heterodimer p65p50, the active form; on the other hand, Christman's group 73, 74 reported a global decrease of NF-κB in tolerized cells. Following in vitro LPS-activation of circulating PBMC of septic patients, we found that the nuclear expression of p65p50 was significantly reduced in all patients with severe sepsis as compared to controls and demonstrated that in the non-survivors, NF-κB was mostly composed of the inactive form p50p50. 71 This down-regulation of NF-κB in circulating mononuclear cells was also found when the systemic inflammation was not of infectious origin (major trauma) and appeared to be a long lasting phenomenon. 75 In a rat model of hemorrhagic shock, nuclei from peritoneal macrophages showed NF-κB activation at baseline that was minimally augmented upon LPS stimulation as compared to the upregulation in controls. 62 Altogether, these observations suggest a down-regulated expression of NF-κB in circulating leukocytes of SIRS patients, which stands in contrast with the activated translocation of NF-κB found in cells derived from other compartments and tissues.
At homeostasis, NF-κB is complexed within the cytoplasm with its inhibitor IκB. In sepsis 71 and in trauma patients 75 , IκBα expression in PBMC was very low. Interestingly, we showed that IκBα resynthesis which can be induced in PBMC of healthy controls briefly after activation with LPS or Staph. aureus, could only be induced by Staph. aureus in PBMC of trauma patients. 75 This further illustrates the discrepancy of responsiveness which exists depending upon the nature of the triggering signal.
The different status of circulating and tissue leukocytes has been further illustrated by the work of Abraham et al. 76 who showed that mitogen-activated protein kinase kinase MEK1/2 and ERK2 were activated in lung PMN but not in blood PMN after hemorrhage or endotoxemia. A similar pattern was obtained when cAMP element binding protein (CREB) was analyzed.
Because of its fundamental role in acute inflammation, NF-κB has been chosen by several investigators as a target for the treatment of sepsis. Inhibitors of NF-κB, such as dithiocarbamate (PDTC) or N-acetyl-leucinylleucinyl-norleucinal (a potent inhibitor of the proteasome pathway) were tested in animal models of endotoxin shock. The treatment with these inhibitors decreased nitric oxide synthase expression within the tissues, 77 TNF and IL-6 levels in the serum, 78 and reduced microvascular injury and disseminated intravascular coagulation. 79, 80 The limit of these studies is that in all but one, 80 the inhibitors had to be administrated before the LPS challenge in order to be effective. Furthermore, at high dose PDTC is toxic and has non-specific effects: it can activate AP-1 which is another transcription factor that induces pro-inflammatory cytokines as well. Finally, even if NF-κB is the major transcription factor involved in the pro-inflammatory cascade, its blockage may not be sufficient as other transcription factors, such as AP-1, NF-IL6 or CREB can also take part in the induction of inflammatory mediators. Our observation on a dysregulation of NF-κB translocation in PBMC of patients with severe sepsis and the low level of cytoplasmic IκBα suggest that although the use of drugs targeting NF-κB in animal models of sepsis was successful, this approach may not be appropriate to cure septic patients, unless they can be delivered at the onset of inflammation or within defined compartments where the inflammatory process keeps going on.
CONCLUSIONS
In this brief review, we have attempted to demonstrate that the inflammatory process observed in sepsis and SIRS patients mainly occurs within the tissues whereas the antiinflammatory response occurs at the systemic level (Fig.  2) . We postulate that both events occur concomitantly while a two waves phenomenon has been often suggested. 81 How can we consider this cell adaptation on a teleological point of view? Munford and Pugin 82 illustrate that 'the body's normal response to stress usually prevent systemic inflammation'. They emphasize that 'the adaptations to stresses involve a co-ordinating local inflammation with systemic anti-inflammation which enables the body to concentrate activated phagocytes and other effectors at an injured or infected local site while preventing potentially damaging inflammation in uninvolved tissues'. A limited inflammatory process within the blood stream should avoid fatal clotting or aggressive proteolysis of the endothelium surface. Indeed, activated circulating monocytes or neutrophils are rapidly eliminated from the blood compartment and marginate towards the inflammatory foci. The price of these normal events is the occurrence of an immune depression as revealed by the decreased capacity of collected circulating cells to produce cytokines in in vitro test.
Today, efforts should be made to further understand the molecular basis of the Natura medicatrix defined by Louis Pasteur when he studied puerperal septicemia. More than ever, we definitely need to increase our knowledge about diseased humans. Accordingly, we should continue our efforts in clinical research to define what occurs in 'real life' and pursue fundamental investigations to define better 90 Cavaillon, Adib-Conquy, Cloëz-Tayarani, Fitting Fig. 2 . Hypothetical schematic representation of the compartmentalized inflammatory response in sepsis and non-infectious systemic inflammatory response syndrome. The systemic inflammatory response syndrome is associated with an exacerbated inflammatory response which predominates in tissues where isolated leukocytes show enhanced cytokine production as assessed by the enhanced levels of both pro-and anti-inflammatory cytokines detectable in biological fluids and in plasma. In contrast, the anti-inflammatory response which occurs concomitantly, mainly affects the leukocytes from the hematopoietic compartments as assessed by their decreased in vitro ability to produce cytokine upon LPS stimulation. However, the use of other triggering agents suggest that hyporeactivity does not affect all signalling pathways.
